Replies to post #425 on Ariad Pharmaceuticals Inc fka ARIA

[vidpok45]

In the final analysis, whether we partner now or later I think we can agree that the prospects for Ariad over the next year are looking better than at any time I can remember since 2000. If you are willing to share your other favorite biotechs it would be very much appreciated by those of us who have great respect for your opinions.

[chazzzzz]

Don, even though the company may have enough cash to last thru the better half of next year, the perfect scenario would be if the RIDA analysis came positive. Of Course the stock would rise and then the company would be able to go the market and sell equity. Even though there would be dilution, 10 million shares @ $7.00 would pretty much cover AP534 without much partnering.

Even though we think that AP534 is the key to the future, I think that RIDA's analysis is key to the future of the Ap534 and its timeliness to market.

[joyakid]

ARIA needs to negotiate from a point of strength. Therefore, the better the results for rida and, so far as we know especially 534 (which is there already), the stronger ARIA will certainly be. Then potential partners will be knocking at our doors. Watch out! Go ArIa!

Best,

j..